Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates
Titel:
Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates
Auteur:
Kelley, R.K. Nimeiri, H.S. Munster, P.N. Vergo, M.T. Huang, Y. Li, C.-M. Hwang, J. Mulcahy, M.F. Yeh, B.M. Kuhn, P. Luttgen, M.S. Grabowsky, J.A. Stucky-Marshall, L. Korn, W.M. Ko, A.H. Bergsland, E.K. Benson III, A.B. Venook, A.P.